Search research articles
Contact Us
Filters
Showing results (51-60 of 168) with videos related to
Page
of 17
Sort By:
The Oncologist
|
September 30, 2016
Broad Detection of Alterations Predicted to Confer Lack of Benefit From EGFR Antibodies or Sensitivity to Targeted Therapy in Advanced Colorectal Cancer
Andrew Rankin, Samuel J Klempner, Rachel Erlich, et al.
Breast Cancer Research and Treatment
|
October 14, 2015
Comprehensive genomic profiling of inflammatory breast cancer cases reveals a high frequency of clinically relevant genomic alterations
Jeffrey S Ross, Siraj M Ali, Kai Wang, et al.
Clinical Breast Cancer
|
November 9, 2013
Antitumor response of an ERBB2 amplified inflammatory breast carcinoma with EGFR mutation to the EGFR-TKI erlotinib
Siraj M Ali, R Kathy Alpaugh, Jamie K Buell, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 17, 2012
Next-generation sequencing identifies and immunohistochemistry confirms a novel crizotinib-sensitive ALK rearrangement in a patient with metastatic non-small-cell lung cancer
Nir Peled, Gary Palmer, Fred R Hirsch, et al.
Archives of Pathology & Laboratory Medicine
|
May 1, 2015
Genomic profiling of advanced-stage, metaplastic breast carcinoma by next-generation sequencing reveals frequent, targetable genomic abnormalities and potential new treatment options
Jeffrey S Ross, Sunil Badve, Kai Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 2, 2016
Personalized Treatment for a Patient With a BRAF V600E Mutation Using Dabrafenib and a Tumor Treatment Fields Device in a High-Grade Glioma Arising From Ganglioglioma
Silviya K Meletath, Dean Pavlick, Tim Brennan, et al.
Pediatric Blood & Cancer
|
January 19, 2017
Identification of NTRK fusions in pediatric mesenchymal tumors
Dean Pavlick, Alexa B Schrock, Denise Malicki, et al.
British Journal of Haematology
|
June 14, 2016
Unique genomic features in adolescent and young adult, as compared to older adult, non-Hodgkin lymphoma and potential therapeutic targets
Adrienne Johnson, Deborah Morosini, Jo-Anne Vergilio, et al.
The Oncologist
|
September 4, 2015
Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences
Kai Wang, Adrienne Johnson, Siraj M Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 19, 2013
BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition
Katherine E Hutchinson, Doron Lipson, Philip J Stephens, et al.
Page
of 17
Search research articles
Search
Showing results (51-60 of 168) with videos related to
Sort By:
Page
of 17
The Oncologist
|
September 30, 2016
Broad Detection of Alterations Predicted to Confer Lack of Benefit From EGFR Antibodies or Sensitivity to Targeted Therapy in Advanced Colorectal Cancer
Andrew Rankin, Samuel J Klempner, Rachel Erlich, et al.
Breast Cancer Research and Treatment
|
October 14, 2015
Comprehensive genomic profiling of inflammatory breast cancer cases reveals a high frequency of clinically relevant genomic alterations
Jeffrey S Ross, Siraj M Ali, Kai Wang, et al.
Clinical Breast Cancer
|
November 9, 2013
Antitumor response of an ERBB2 amplified inflammatory breast carcinoma with EGFR mutation to the EGFR-TKI erlotinib
Siraj M Ali, R Kathy Alpaugh, Jamie K Buell, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 17, 2012
Next-generation sequencing identifies and immunohistochemistry confirms a novel crizotinib-sensitive ALK rearrangement in a patient with metastatic non-small-cell lung cancer
Nir Peled, Gary Palmer, Fred R Hirsch, et al.
Archives of Pathology & Laboratory Medicine
|
May 1, 2015
Genomic profiling of advanced-stage, metaplastic breast carcinoma by next-generation sequencing reveals frequent, targetable genomic abnormalities and potential new treatment options
Jeffrey S Ross, Sunil Badve, Kai Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 2, 2016
Personalized Treatment for a Patient With a BRAF V600E Mutation Using Dabrafenib and a Tumor Treatment Fields Device in a High-Grade Glioma Arising From Ganglioglioma
Silviya K Meletath, Dean Pavlick, Tim Brennan, et al.
Pediatric Blood & Cancer
|
January 19, 2017
Identification of NTRK fusions in pediatric mesenchymal tumors
Dean Pavlick, Alexa B Schrock, Denise Malicki, et al.
British Journal of Haematology
|
June 14, 2016
Unique genomic features in adolescent and young adult, as compared to older adult, non-Hodgkin lymphoma and potential therapeutic targets
Adrienne Johnson, Deborah Morosini, Jo-Anne Vergilio, et al.
The Oncologist
|
September 4, 2015
Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences
Kai Wang, Adrienne Johnson, Siraj M Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 19, 2013
BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition
Katherine E Hutchinson, Doron Lipson, Philip J Stephens, et al.
Page
of 17